| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4218671 | Academic Radiology | 2013 | 9 Pages |
Abstract
Baseline whole-body metabolic tumor burden as measured with MTVWB and TLGWB on FDG PET is a prognostic measure independent of clinical stage and other prognostic factors including chemoradiation therapy and surgical procedure with low interobserver variability and may be used to further risk stratify surgical patients with NSCLC. This study also suggests that MTV and TLG are better prognostic measures than SUVmax and SUVmean. These results will need to be validated in larger cohorts in a prospective study.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Hao MD, PhD, Kristen MS, Shengri MD, PhD, Rony MD, Bill C. PhD, Yi MD, Yonglin MD, PhD,